TabletsTablets
Schedule H (Prescription Required)Broad-Spectrum AntibioticsCode: 1615

Erythromycin Stearate Tablets 500mg

Generic Formulation:Erythromycin Stearate Tablets IP 500mg
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹53.44
Brand Estimate*
₹130.41
Estimated Savings:₹76.97 (59% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Erythromycin is the prototypical macrolide antibiotic produced by Saccharopolyspora erythraea. It inhibits protein synthesis by binding to the 50S ribosomal subunit. Effective against Gram-positive bacteria, atypical pathogens, and Bordetella pertussis. Indicated for respiratory tract infections, pertussis, diphtheria, syphilis in penicillin-allergic patients, and prophylaxis of neonatal chlamydial conjunctivitis.

Active Pharmaceutical Ingredients

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 1615.Report inaccuracy

Usage Guidelines

Take orally on an empty stomach with a full glass of water, 1 hour before or 2 hours after meals. If gastric distress occurs, taking with light food is permissible. Space doses evenly throughout the day.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Abdominal cramping, nausea, vomiting, diarrhea, and anorexia. Rare/Severe: Cholestatic hepatitis, QT prolongation, torsades de pointes, reversible sensorineural hearing loss (at high doses), and infantile hypertrophic pyloric stenosis in neonates.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Potent inhibitor of CYP3A4; interacts with carbamazepine, theophylline, warfarin, and ergot alkaloids. Contraindicated in severe liver disease or co-administration with terfenadine/astemizole/cisapride.

Schedule H (Prescription Required)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.